- Report
- October 2025
- 50 Pages
Global
From €2361EUR$2,650USD£2,054GBP
- Report
- January 2025
- 175 Pages
Global
From €4000EUR$4,490USD£3,480GBP
- Report
- February 2021
- 420 Pages
United States
From €2138EUR$2,400USD£1,860GBP
- Report
- October 2025
- 50 Pages
Global
From €2361EUR$2,650USD£2,054GBP
Maprotiline is a tricyclic antidepressant (TCA) used to treat mental disorders such as depression, anxiety, and panic disorder. It is a monoamine reuptake inhibitor, meaning it works by blocking the reuptake of serotonin and norepinephrine in the brain. Maprotiline is also used to treat chronic pain, and is sometimes used off-label to treat ADHD.
Maprotiline is a generic drug, meaning it is available in generic form and is much less expensive than brand-name drugs. It is available in both oral and injectable forms, and is usually taken once or twice a day. Common side effects include dry mouth, constipation, dizziness, and drowsiness.
The Maprotiline market is a competitive one, with many companies offering generic versions of the drug. Some of the companies in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more